DOJ Gets In on Teva Pharmaceutical Bribery Probe
By Douglas Gillison | November 2, 2012 4:12 pm

The Justice Department has joined the Securities and Exchange Commission in scrutinizing the Israeli generic drug producer Teva Pharmaceutical Industries Ltd. for potential foreign bribery violations, according to a regulatory filing.

The company disclosed in August that it had hired outside counsel after being subpoenaed by the SEC in July about its operations in Latin America.

In a 6-K foreign issuer’s report filed Thursday with the SEC, the company said it had also received “informal document requests” from the Justice Department on Oct. 10 and Oct. 26. The company says it is also conducting an internal review.

Based in the city of Petah Tikva east of Jerusalem, the company boasts of a 20 percent share of the U.S. market, with 1.5 million prescriptions for its drugs written by U.S. doctors every day. The company is traded on the New York Stock Exchange via American Depositary Receipts and reported a 14 percent year-on-year rise in third-quarter net revenues to $5 billion.

Here is the relevant text from Thursday’s filing:

Teva received a subpoena dated July 9, 2012 from the SEC to produce documents with respect to compliance with the Foreign Corrupt Practice Act (“FCPA”) in Latin America. On October 10 and October 26, 2012, the Department of Justice sent informal document requests to the Company as well. Teva is cooperating with the government. Teva is also conducting a voluntary investigation into certain business practices which may have FCPA implications and has engaged independent counsel to assist in its investigation. These matters are in their early stages, and no conclusion can be drawn at this time as to any likely outcomes.

Previous coverage by Just Anti-Corruption:

Friday, August 3, 2012
Facebook Twitter Linkedin Email

Leave a Comment

You must be logged in to post a comment.

Ernst & Young LLP
Dealing with complex issues of fraud, regulatory compliance and business disputes can detract from efforts to succ... more
Pillsbury Winthrop Shaw Pittman
ANALYSIS: Does Our Insurance Cover This? Coverage for Actions in Response to Governmental Investigations and Prose... more
Sheppard, Mullin, Richter & Hampton LLP
ANALYSIS: Beyond the Checklist: Seven Keys to Effective Trade Due Diligence more
Clifford Chance
ANALYSIS: Is the Paper Tiger Sharpening Its Teeth? SFO is Building a Portfolio of High-Profile International Bribe... more
White & Case LLP
ANALYSIS: The Long Arm of the Law - Exporting US Justice more
Orrick, Herrington & Sutcliffe LLP
ANALYSIS: For Now, The Broad Interpretation of “Foreign Officials” Under the FCPA Is Here to Stay more
Baker & McKenzie
ANALYSIS: Spotlight on FinCEN: An Increasing Focus on AML Regulation and Enforcement more

Clip from President Obama and Eric Holder announcement of Holder's resignation.


RACHEL MADDOW SUMS UP HOLDER's TENURE: One of the "most consequential" attorneys generals in history faced irrational conservative hatred, MSNBC host says.